MannKind Corporation News
Cramer's Mad Money Recap: Nonfarm Payrolls, Micron, Bed Bath & Beyond
Latest nonfarm payrolls report will dominate Wall Street in week ahead, but fresh financial results are due from tech and meme names as well.
Medicinova Jumps on Phase 2 Progress With Alcohol-Abuse Drug
Medicinova's clinical trials found that its ibudilast reduced the odds of heavy drinking over time by 45% relative to a placebo.
Nanox Higher on Application to FDA for Medical Imaging System
Nanox shares climbed after the medical-imaging-tech company applied to the FDA for clearance of a system that produces scans of human body parts.
Altimmune Higher After Phase 1 Progress With Obesity Drug
Altimmune jumped after it reported progress from its Phase 1 trial of ALT-801, a drug for obesity and liver disease.
MannKind Shares Rise as Partner's Drug Gets FDA Priority Review
The FDA granted priority review for a lung-disease medicine being developed by Mannkind's partner, United Therapeutics.
Disney Mobile Game Opens Up a New Universe
Familiar Disney characters populate an alternate reality in new interactive game.
Birth Control Stocks May Benefit From the Reversal of Roe v. Wade
The historic Supreme Court decision may force women to make different choices.
Roe Decision Forces Disney, Netflix to Take a Political Stand
Disney, JP Morgan Chase, and outgoing Meta COO Sheryl Sandberg are just a few speaking out against the ruling.